Skip to content

Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation

Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation Following Open Heart Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00541541
Enrollment
Unknown
Registered
2007-10-10
Start date
2007-02-28
Completion date
Unknown
Last updated
2013-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Pacing, Artificial, Heart Failure, Congestive, Transcutaneous Electric Nerve Stimulation

Brief summary

In this study, the investigators sought to determine whether a stimulation of the phrenic nerve affects heart function. Heart function is assessed by acoustic cardiography.

Detailed description

Patients who need temporary pacing following open heart surgery and who are willing to participate receive a phrenic nerve electrode during the operation. Heart function is postoperatively assessed by acoustic cardiography (Audicor, Inovise Medical Inc., Portland, USA) during different forms of pacing (right ventricle, left ventricle, biventricular; AAI, DDD) and with or without phrenic nerve stimulation. Acoustic cardiography simultaneously integrates heart sounds and single-channel electrocardiography input to generate multiple parameters that correlate to established hemodynamic measures. Effects of phrenic nerve stimulation on heart function will be analyzed.

Interventions

Patients receive a phrenic nerve stimulation

Sponsors

Inovise Medical
CollaboratorINDUSTRY
Luzerner Kantonsspital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients following open heart surgery who need temporary pacing

Exclusion criteria

* Patients with permanent pacemakers * Patients with fast changing need of vasopressor therapy

Design outcomes

Primary

MeasureTime frame
Change of electrical mechanical activation time (EMAT) as measure of heart function on different settings of pacingOne day

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026